Status:
COMPLETED
eMBC for Perinatal Depression and Anxiety
Lead Sponsor:
Women's College Hospital
Conditions:
Depression, Postpartum
Anxiety
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Depression and anxiety that occur around the time of pregnancy can adversely impact a person's health and well-being, and their child's health and development. Fewer than 20% of affected people are ad...
Detailed Description
A parallel group randomized controlled trial (RCT) will be conducted. Eligible and consenting patients with depression and/or anxiety will be randomized in a 1:1 ratio to either the eMBC condition or ...
Eligibility Criteria
Inclusion
- Age ≥18
- Currently pregnant or mother\* of a live infant 0-12 months of age and living at the same residence
- \*Through natural birth, adoption, surrogacy, including cis women, non-binary and transgender people in all their diversity
- EPDS \>12 at enrollment
Exclusion
- Active suicidal ideation, substance abuse or dependence
- Current or past mania or psychosis or current major depressive episode with psychosis
- 4\. Incapable of consenting to participation 5. Unable to read or unable to speak English
Key Trial Info
Start Date :
January 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04836585
Start Date
January 4 2022
End Date
June 30 2024
Last Update
July 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women's College Hospital
Toronto, Ontario, Canada, M5S 1B2